Results 201 to 210 of about 180,947 (337)

P269 A new dedicated capsule for diagnosis and monitoring of Crohn’s disease. First patient series [PDF]

open access: bronze, 2018
Carlo Calabrese   +6 more
openalex   +1 more source

Comparative risk of serious infection among biologic therapies for inflammatory bowel disease in pediatric patients: A target trial emulation

open access: yes
Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Serena Yun‐Chen Tsai   +3 more
wiley   +1 more source

Real‐world data on STRIDE‐II treatment targets in a pediatric cohort with inflammatory bowel disease

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives STRIDE (selecting therapeutic targets in inflammatory bowel disease) established evidence‐based targets for treat‐to‐target strategies in IBD. STRIDE‐II designates clinical remission, C‐reactive protein (CRP) normalization, and fecal calprotectin (FC) reduction as short‐ to intermediate‐term targets, and mucosal healing as a long ...
Marie‐Luise Frank   +9 more
wiley   +1 more source

P048 Mucosal macrophages express elevated levels of HDAC9 in inflamed and uninflamed mucosa of Crohn’s disease, but not ulcerative colitis [PDF]

open access: bronze, 2020
Mohammed Ghiboub   +8 more
openalex   +1 more source

The attitudes and beliefs of Australasian pediatric gastroenterologists and dietitians toward the Crohn's disease exclusion diet

open access: yesJPGN Reports, EarlyView.
Abstract Objectives Nutritional therapy plays a crucial role in managing pediatric Crohn's disease (CD). Exclusive enteral nutrition (EEN) is the primary induction therapy, achieving high remission and mucosal healing rates. However, its restrictive nature poses psychological and practical challenges.
Stephanie C. Brown   +4 more
wiley   +1 more source

A case of autoimmune hepatitis in a patient with inflammatory bowel disease and significant lymphadenopathy in the porta hepatis

open access: yesJPGN Reports, EarlyView.
Abstract The diagnosis of autoimmune hepatitis (AIH) is supported by the presence of elevated transaminases, hypergammaglobulinemia, liver biopsy consistent with AIH, and the presence of AIH autoantibodies. In this case presentation, we highlight the challenges associated with diagnosing AIH in a patient with inflammatory bowel disease (IBD) who ...
Benjamin J. Malamet   +5 more
wiley   +1 more source

Evidence-based efficacy of methotrexate in adult Crohn’s disease in different intestinal and extraintestinal indications [PDF]

open access: gold, 2022
A. Cassinotti   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy